Decipher Labs Ltd Share Price Today - Decipher Labs Ltd Stock Price Live NSE/BSE

Decipher Labs Ltd

NSE: BSE: 524752

₹6

(-3.07%)

Fri, 13 Mar 2026, 10:08 pm

MTF 5xInvest in Decipher Labs Ltd with 5x Leverage Buy with MTF

Market Cap0

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Decipher Labs Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
6.55
Net Profit
-5.08
P/B
0.46
Sector P/E
32.90
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
10.03
ROCE (Industry)
12.82
RONW (Industry)
12.23
ROE
1.16
ROCE
-4.66
Debt/Equity
0.01
EPS (TTM)
0
Dividend Yield
0
Book Value
18.95
Interest Cover
0

Analysis

all

Pros

Decipher Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Decipher Labs is profitable, therefore cash runway is not a concern.
Decipher Labs is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (82.3%, greater than 20% of total debt).
Debt is covered by short term assets, assets are 13.6x debt.

Cons

Unable to evaluate Decipher Labs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Decipher Labs's dividend against the top 25% market benchmark as the company has not reported any payouts.
The level of debt compared to net worth has increased over the past 5 years (0.7% vs 10.7% today).
High level of physical assets or inventory.
Decipher Labs is not covered by any analysts.

Financials

No Result Found

Ratios

No Result Found

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	16.43	16.43	16.43	16.43	16.43
FII	0	0	0	0	0
DII	0.00	0.00	0.00	0.00	0.00
Public	83.57	83.57	83.57	83.57	83.57
Government	0	0	0	0	0

Technical Analysis

RSI

35.94

MACD

-0.59

50 DMA

7.94

200 DMA

9.88

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	11.22	9.53	8.46	7.84	6.77	6.15	4.46
Fibonacci	9.53	8.88	8.48	7.84	7.19	6.79	6.15
Camarilla	7.86	7.71	7.55	7.84	7.25	7.09	6.94

Pivots Level: Classic

+3.38

11.22

+1.69

9.53

+0.63

8.46

7.84

Pivot Point

LTP: 6.11

-1.06

6.77

-1.69

6.15

-3.38

4.46

Moving Average

SMAEMA

Period

Value

10-EMA
6.44
20-EMA
6.92
30-EMA
7.27
50-EMA
7.78
100-EMA
8.62
200-EMA
9.82

Announcement Date	Purpose	Action
12 Feb 2026	board-meetings	Quarterly Results, Nine Months Results
19 Jan 2026	egm
13 Nov 2025	board-meetings	Quarterly Results
15 Sept 2025	agm
13 Sept 2024	agm
04 Sept 2023	agm
11 Apr 2023	egm
08 Sept 2022	agm
07 Mar 2022	egm
26 Aug 2021	agm

Peer Comparison

No Result Found

Decipher Labs Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Lupin Ltd

Decipher Labs Ltd About

Decipher Labs is engaged deals in trading and manufacturing of Pharmaceutical drugs.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1986

Headquarters

CEO

Employees

Contact

Website

http://www.decipherlabs.in

info@decipherlabs.in; cs@decipherlabs.in

Phone

Location

4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2, Hyderabad, Telangana, 500034

Year	History
1986	M/s. Combat Drugs Limited was incorporated as a Private Limited Company on 18th September.
1987	The Commercial Production of the company started on a Loan Licence basis in July.
1988	The company commenced production from the manufacturing unit located at Balanagar, Hyderabad in August.
1992	The Company was converted into a Public Limited Company on 11th June. The Manufacturing activities of the Company were shifted to the present leased premises at 18A, Kushaiguda, Hyderabad in July. The Lease for the present premises was initiated for a period of 3 years starting from June.
2011	The Company approved the scheme of arrangement between the company and its members and unsecured creditors.

Client Name	Order Side	QTY	Avg Price	Date
VINAY KUMAR PRODDATUR	Buy	57052	23.94	12 Jun 2024
MEHULKUMAR NATUBHAI PANUCHA	Sell	106382	23.26	12 Jun 2024
KRUNALKUMAR KANUJI THAKOR	Buy	7634	23.88	12 Jun 2024
VINAY KUMAR PRODDATUR	Sell	57052	21.18	12 Jun 2024
MEHULKUMAR NATUBHAI PANUCHA	Buy	144337	24.12	12 Jun 2024
KRUNALKUMAR KANUJI THAKOR	Sell	73134	24	12 Jun 2024
KRUNALKUMAR KANUJI THAKOR	Buy	66032	19.2	11 Jun 2024
KRUNALKUMAR KANUJI THAKOR	Sell	532	18	11 Jun 2024
RAJESH MANUBHAI SHAH	Sell	71000	14.94	15 May 2024
LAKHUBHA SOLANKI	Buy	68968	19.93	02 Jan 2024

Decipher Labs Ltd News

Decipher Labs Q3FY26 Results Show Mixed Performance

Decipher Labs Limited reported Q3FY26 results with standalone revenue of ₹13.40 lakhs vs ₹16.00 lakhs YoY, while consolidated revenue declined to ₹321.26 lakhs from ₹580.47 lakhs YoY.

12 Feb 2026

co actions results

Decipher Labs EGM Resolution Approved Unanimously

Decipher Labs Limited shareholders unanimously approved the appointment of Mr. Dalavath Amar Singh as Director and Whole-Time Director at the EGM held on February 12, 2026.

12 Feb 2026

co actions results

Decipher Labs Reports Quarterly Losses and Appoints New Executive Director

Decipher Labs Limited reported standalone loss before tax of Rs. 5.64 lakhs for the quarter ended September 30, 2025, while consolidated operations showed a loss before tax of Rs. 340.34 lakhs for the half-year period. The pharmaceutical company appointed Mr. Dalavath Amar Singh as Additional Director for two years at Rs. 6 lakh annual remuneration, subject to shareholder approval.

13 Nov 2025

earnings

Decipher Labs Receives Partial Relief from Securities Appellate Tribunal Against SEBI Order

Decipher Labs Ltd received a Securities Appellate Tribunal (SAT) order providing partial relief from a previous SEBI order dated July 31, 2025. The SAT granted a stay on restrictions that prevented the company from dealing in securities for one year. The tribunal also allowed directors Mr. Janakiram Ajjarapu and Mr. Sushant Mohan Lal to sell shares from their demat accounts and suspended coercive action for disgorgement and penalty recovery, subject to depositing 50% of the amount within four weeks. The original SEBI order involved violations related to PFUTP Regulations, PIT Regulations, and LODR Regulations. The company stated there is no impact on its financial, operational, or other activities due to the SAT order.

20 Sept 2025

corporate governance

Decipher Labs Approves Key Appointments and Schedules AGM for September 30, 2025

Decipher Labs Limited's Board of Directors approved several appointments during their September 5, 2025 meeting. The company appointed M/s. Aakanksha Dubey & Co. as Secretarial Auditors for FY 2025-26, and Mr. Sushant Mohan Lal as Internal Auditor for a five-year term from 2025-26 to 2029-30, subject to shareholder approval. The Board also approved the re-appointment of Mrs. Lakshmi Vijaya Nimmala as Independent Director for five years starting February 14, 2026, pending shareholder approval. The company scheduled its Annual General Meeting for September 30, 2025 at 11:00 a.m. via video conference for FY 2024-25. Additionally, M/s. S.S. Reddy & Associates was appointed as scrutinizer for e-voting during the AGM.

05 Sept 2025

corporate governance

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800